Pharma IQ Members

Contract Research Organisation (CRO)

A Contract Research Organisation, also called Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services (for both drugs and medical devices). CROs range from large, international full service organizations to small, niche specialty groups and can offer their clients the experience of moving a new drug or device from its conception to FDA marketing approval without the drug sponsor having to maintain a staff for these services.

AI in Pharma

Drug development approaches a fascinating era as the trend of digitalization introduces sophisticated technologies which can neutralize costly hazards faced in R&D pipelines, according to a new deep-dive report by Pharma IQ.


Contributor: Chanice Henry
Tue, 11/14/2017
Trial Master File Europe 2017

If your company was handed with a notice for a clinical trial inspection right now, what would the reaction be?  A feeling of calm confidence or a rush of slight concern? In this ebook Pharma IQ compared the perspectives of a Clinical Research...

Contributor: Pharma IQ
Fri, 07/14/2017
What CROs and CMOs Can Learn from Q3 Outsourcing Data and 2011 Trends

Nice Insights quarterly Pharmaceutical and Biotechnology Outsourcing Survey is sent to 40,000+ pharmaceutical and biotechnology executives, and with results now published for the first three quarters in 2011, interesting trends begin to emerge.In...

Contributor: Victor Coker and Mark Allen
Wed, 11/02/2011
Pharma IQ

Clinical research organisations, play an essential role within the drug development process. From large international firms, to smaller niche companies, clinical research organisations are relied upon by the pharmaceutical manufacturers to...

Contributor: Pharma IQ
Wed, 10/06/2010
Pharma IQ

Mark Walls, Director of Clinical Pharmacy at Human Genome Sciences, speaks to Andrea Charles from Pharma IQ, about the logistical challenges facing clinical trials and avoiding common mistakes for logistics in emerging countries. He also talks...

Contributor: Pharma IQ
Thu, 08/19/2010